Duff & Phelps Healthcare and Life Sciences team provides Fortune 500 corporations, middle-market and growth companies and financial sponsors access to our valuation and corporate finance services.
Our dedicated team completes nearly 200 healthcare engagements annually, including engagements in healthcare services, Pharmaceuticals, Medical Technology and Life Sciences. As a firm, Duff & Phelps stands alone in our objectivity, deep technical and industry expertise and breadth of advisory services.
Comprehensive support throughout mergers and acquisitions and other corporate transactions.
Healthcare expertise for middle-market M&A transactions.
Fairness and Solvency Opinions
Independent opinions for boards of directors and special committees.
Private Capital Markets
Senior, subordinated and mezzanine debt and venture/private equity for a wide range of transactions.
Transaction Advisory Services
Seamless analytical advisory through the deal continuum, from transaction origination to closing.
Financial Sponsors Group
Dedicated coverage and access to M&A deal-flow for financial sponsors.
Governance, Risk, Investigations and Disputes
Combined Duff & Phelps and Kroll disputes, investigations, cyber, business intelligence, cross-border restructuring and other advisory.
Valuation and consulting for financial reporting, federal, state and local tax, investment and risk management purposes.
Property tax, site selection, transfer pricing, sales and use tax and unclaimed property advisory.
has completed a debt for equity exchange as part of a restructuring transaction
has completed a recapitalization and financial restructuring transaction
Ken Joseph Discusses $38M Broker Fine for Failure to Monitor Suspicious Activity
Srividya Gopal Featured in Mergermarket Talking About M&A Indicators Post COVID-19
David Larsen Talks About LPs Exercising Vigilance
Simon Webber, Judd Schneider and David Ptashne in Tax Notes: Intangible Asset Valuation Considerations